All Resources
App Note
Empowering Rapid and Robust Antibody Response: The Role of Next-Generation Antibody Discovery in Preparedness for Emerging Diseases and Endemic Threats

Learn how leading researchers are revolutionizing Antibody Research during COVID response by harnessing cutting-edge technologies to eliminate epidemic threats.

Your data is secure. We keep your personal information safe and do not share it with any third parties. By submitting this form, you agree to receive communications from Bruker Cellular Analysis and accept our Privacy Policy. You may unsubscribe at any time.

What's Inside

In this App Note we discuss:

How Rapid Antibody Screening with the Beacon® System is Revolutionizing Functional Analysis and Early Antibody Identification.
Identifying Broadly Neutralizing Antibodies for Next Generation Therapeutic mAbs and Vaccines.
Insights from the Beacon on Antibody Expression and Functional Analysis.
Early Identification of Potent Omicron-Neutralizing Antibodies.
Comparative Screening Efficiency and Rapid Lead Identification.
A Deeper Look

More about this App Note

Beacon: A Superhero in the Fight Against Emerging and Endemic Diseases

The Beacon system has been – and will continue to be – an invaluable tool in the global fight against emerging and endemic diseases, especially COVID-19.

By identifying and screening tens of thousands of B cells in just one day, the Beacon can produce a much higher quantity of quality hits more quickly than traditional methods.

Download this app note to learn more about our unique technology and to view case studies.

Get the App Note